Online Pharmaceutical Schedule - June 2022

You are viewing June 2022. View May 2022 Schedule.

HIV Prophylaxis and Treatment

Emtricitabine with tenofovir disoproxil          - Subsidy by endorsement ; can be waived by Special Authority SA1994

Tab 200 mg with tenofovir disoproxil 245 mg (300.6 mg as a succinate)

TICK Teva 2560488 $61.15 per 30

Endorsement for treatment of HIV: Prescription is deemed to be endorsed if emtricitabine with tenofovir disoproxil is co-prescribed with another antiretroviral subsidised under Special Authority SA1651 and the prescription is annotated accordingly by the Pharmacist or endorsed by the prescriber.


Emtricitabine with tenofovir disoproxil prescribed under endorsement for the treatment of HIV is included in the count of up to 4 subsidised antiretrovirals, and counts as two antiretroviral medications, for the purposes of Special Authority SA1651, page 1

There is an approval process to become a named specialist to prescribe antiretroviral therapy in New Zealand. Further information is available on the Pharmac website.

For eye preparations refer to Eye Preparations, Anti-Infective Preparations, page 236